^
CANCER:

Thymus Cancer

Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Related cancers:
No biomarker
Thymic Carcinoma
lenvatinib
Sensitive
:
A1
No biomarker
Thymic Carcinoma
GEM-CAP
Sensitive
:
A2
No biomarker
Thymic Carcinoma
LV5FU2
Sensitive
:
A2
No biomarker
Thymoma
GEM-CAP
Sensitive
:
A2
No biomarker
Thymoma
LV5FU2
Sensitive
:
A2
No biomarker
Thymic Carcinoma
CaT
Sensitive
:
A2
No biomarker
Thymoma
CaT
Sensitive
:
A2
KIT mutation
Thymic Carcinoma
sunitinib
Sensitive
:
A2
No biomarker
Thymoma
VIP
Sensitive
:
A2
No biomarker
Thymic Carcinoma
VIP
Sensitive
:
A2
No biomarker
Thymoma
CAP
Sensitive
:
A2
No biomarker
Thymoma
etoposide IV
Sensitive
:
A2
No biomarker
Thymoma
ifosfamide
Sensitive
:
A2
No biomarker
Thymic Carcinoma
EP
Sensitive
:
A2
No biomarker
Thymic Carcinoma
ADOC
Sensitive
:
A2
No biomarker
Thymic Carcinoma
CAP + prednisone
Sensitive
:
A2
No biomarker
Thymic Carcinoma
CAP
Sensitive
:
A2
No biomarker
Thymoma
CAP + prednisone
Sensitive
:
A2
No biomarker
Thymoma
ADOC
Sensitive
:
A2
No biomarker
Thymoma
EP
Sensitive
:
A2
No biomarker
Thymic Carcinoma
carboplatin
Sensitive
:
A2
No biomarker
Thymic Carcinoma
paclitaxel
Sensitive
:
A2
No biomarker
Thymoma
carboplatin
Sensitive
:
A2
No biomarker
Thymoma
pembrolizumab
Resistant
:
A2
No biomarker
Thymic Carcinoma
ifosfamide
Sensitive
:
A2
No biomarker
Thymic Carcinoma
etoposide oral
Sensitive
:
A2
No biomarker
Thymic Carcinoma
pembrolizumab
Sensitive
:
A2
No biomarker
Thymic Carcinoma
gemcitabine
Sensitive
:
A2
No biomarker
Thymic Carcinoma
prednisone + octreotide
Sensitive
:
A2
No biomarker
Thymic Carcinoma
octreotide
Sensitive
:
A2
No biomarker
Thymic Carcinoma
everolimus
Sensitive
:
A2
No biomarker
Thymic Carcinoma
pemetrexed
Sensitive
:
A2